| Literature DB >> 35521510 |
Mayura Soonwera1, Tanapoom Moungthipmalai1, Jirapon Aungtikun1, Sirawut Sittichok1.
Abstract
Extensive uses of synthetic insecticides to control mosquito's populations have induced the insects to develop resistance against them, rendering them ineffective today. Moreover, they cause serious impacts on human health and the ecosystem. Therefore, safe and effective natural alternatives are needed. This study evaluated the larvicidal and pupicidal activities of essential oils (EOs) from Illicium verum and Zanthoxylum limonella and the major constituents against Aedes aegypti and Aedes albopictus mosquitoes as well as recorded their morphological aberrations at death. The GC-MS analysis showed that trans-anethole was the major constituent of I. verum EO, and limonene was the major constituent of Z. limonella EO. Both were more effective against the larvae and pupae of Ae. aegypti than those of Ae. albopictus. A 2.5% I. verum EO + 2.5% trans-anethole combination showed the highest larvicidal and pupicidal effects against Ae. aegypti and Ae. albopictus with an LT50 ranging from 0.2-6.9 h. Between the two tested constituents, trans-anethole exhibited stronger larvicidal and pupicidal activities (LC50 ranging 2.4-3.4%) against the two tested mosquito species than d-limonene (LC50 ranging 2.5-3.7%). Most importantly, 5% trans-anethole, 5% d-limonene, and 2.5% I. verum EO + 2.5% trans-anethole were more effective (LT50 ranging 0.1-0.3 h) than 1% (w/w) temephos (LT50 ranging 2.9-3.1 h). Morphological aberrations at death observed were such as color pigment and thorax shape abnormalities. To conclude, trans-anethole, d-limonene, and a combination of I. verum EO + trans-anethole, are natural compounds that not only are as effective as temephos at the time of this study, but should be also be much safer to human health.Entities:
Keywords: Aedes aegypti; Aedes albopictus; Illicium verum EO; Larvicidal activity; Pupicidal activity; Trans-anethole
Year: 2022 PMID: 35521510 PMCID: PMC9065628 DOI: 10.1016/j.heliyon.2022.e09346
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Major chemical constituents of EOs from I. verum (a) and Z. limonella (b).
List of chemical constituents of I. verum and Z. limonella essential oils.
| Item | Compound | Peak area % | RI | KI | Mode of identification | |
|---|---|---|---|---|---|---|
| 1 | Cyclopentane | - | 0.71 | 721 | 720 | RI, MS |
| 2 | α-Thujene | 0.09 | 2.28 | 923 | 923 | RI, MS |
| 3 | α-Pinene | 0.11 | 1.72 | 933 | 933 | RI, MS |
| 4 | Benzene | 0.57 | 7.48 | 938 | 938 | RI, MS |
| 5 | Sabinene | - | 4.46 | 973 | 973 | RI, MS |
| 6 | β-Myrcene | - | 0.38 | 983 | 983 | RI, MS |
| 7 | α-Phellandrene | - | 1.29 | 992 | 992 | RI, MS |
| 8 | α-Terpinene | 0.07 | 6.13 | 1015 | 1015 | RI, MS |
| 9 | 3-Carene | 0.20 | 0.29 | 1017 | 1017 | RI, MS |
| 10 | 1.70 | 1018 | 1018 | RI, MS | ||
| 11 | 1,8-Cineole | 0.35 | - | 1024 | 1025 | RI, MS |
| 12 | trans-β-Ocimene | - | 0.30 | 1043 | 1043 | RI, MS |
| 13 | γ-Terpinene | - | 6.82 | 1048 | 1048 | RI, MS |
| 14 | Linalyl oxide | 0.08 | - | 1077 | 1077 | RI, MS |
| 15 | Terpinolene | 0.11 | 2.20 | 1084 | 1084 | RI, MS |
| 16 | Linalool | - | 1.05 | 1085 | 1085 | RI, MS |
| 17 | 3-Cyclohexene-1-ol | 0.13 | - | 1096 | 1097 | RI, MS |
| 18 | Cyclohexanone | - | 0.45 | 1122 | 1122 | RI, MS |
| 19 | Sabina ketone | - | 0.70 | 1157 | 1158 | RI, MS |
| 20 | Terpinen-4-ol | - | 22.11 | 1174 | 1174 | RI, MS |
| 21 | α-Terpineol | 0.36 | 4.49 | 1179 | 1179 | RI, MS |
| 22 | trans-Carveol | - | 2.27 | 1217 | 1217 | RI, MS |
| 23 | Carvone | - | 2.38 | 1242 | 1242 | RI, MS |
| 24 | Carvotanacetone | - | 0.60 | 1243 | 1243 | RI, MS |
| 25 | Anisaldehyde | 1.55 | - | 1262 | 1262 | RI, MS |
| 26 | - | 1288 | 1288 | RI, MS | ||
| 27 | Carvacrol | 1.17 | 1298 | 1298 | RI, MS | |
| 28 | Eugenol | 0.62 | - | 1351 | 1351 | RI, MS |
| 29 | Acetic acid | - | 0.91 | 1404 | 1404 | RI, MS |
| 30 | β-Caryophyllene | - | 0.12 | 1418 | 1418 | RI, MS |
| 31 | Anisyl acetone | 0.35 | - | 1462 | 1462 | RI, MS |
| 32 | Spathulenol | - | 0.29 | 1575 | 1575 | RI, MS |
| 33 | Caryophyllene oxide | - | 0.25 | 1580 | 1581 | RI, MS |
| Total | 99.87 | 97.27 | ||||
RI = Retention index, MS = Mass spectra.
Identified constituents are listed in their order of elution.
RI are retention indices calculated against C7–C30 n-alkanes with HP-5MS column.
KI = Kovats Retention Index is taken from https://pubchem.ncbi.nlm.nih.gov.
Figure 2Relationship between mortality rate and exposure period of Ae. aegypti and Ae. albopictus larvae (a,b) and pupae (c,d) exposed to 5% d-limonene and 5% trans-anethole.
Figure 3Relationship between mortality rate and exposure period of Ae. aegypti and Ae. albopictus larvae (a,b) and pupae (c,d) exposed to a combined formulation of EO and EO constituent.
Mortality rate at 6 h, lethal time for 50% and 90% mortality, and lethal concentration for 50% mortality of every treatment against fourth instar larvae of Ae. aegypti and Ae. albopictus.
| Mosquito Species | Treatment | Conc. (%) | LAI | Mortality (%) ± SD at 6 h | Slope ±SE | LT50 | LT90 | χ2 | LC50 | |
|---|---|---|---|---|---|---|---|---|---|---|
| d-limonene | 0.5 | 4.24 | 4.8 ± 3.3g | 0.005 ± 0.002 | 12.3 (9.2–26.6) | 16.7 (11.9–39.6) | 13.2 | 0.111 | 2.9 (1.5–3.9) | |
| 1 | 4.21 | 35.2 ± 4.4e | 0.003 ± 0.000 | 12.2 (9.5–17.6) | 20.3 (15.6–29.9) | 46.6 | 0.377 | |||
| 2.5 | 0.17 | 52.6 ± 5.3d | 0.012 ± 0.000 | 0.6 (0.4–1.0) | 0.9 (0.5–1.1) | 86.5 | 0.450 | |||
| 5 | 0.07 | 100a | 0.217 ± 0.013 | 0.2 (-) | 0.3 (-) | 92.3 | 0.500 | |||
| trans-anethole | 0.5 | 5.86 | 8.0 ± 3.3f | 0.003 ± 0.001 | 16.7 (11.4–36.4) | 24.5 (16.4–55.3) | 51.9 | 0.015 | 2.5 (0.8–3.0) | |
| 1 | 0.72 | 70.8 ± 7.1cd | 0.008 ± 0.000 | 2.1 (1.6–3.0) | 4.9 (2.4–6.3) | 338.4 | 0.537 | |||
| 2.5 | 0.13 | 97.5 ± 4.1b | 0.125 ± 0.006 | 0.4 (0.2–0.5) | 0.7 (0.4–0.9) | 88.2 | 0.752 | |||
| 5 | 0.07 | 100a | 0.114 ± 0.006 | 0.2 (-) | 0.4 (-) | 94.6 | 0.804 | |||
| 2.5% | - | 0.03 | 100a | 0.095 ± 0.006 | 0.1 (-) | 0.3 (-) | 2.6 | 0.156 | ||
| 2.5% | - | 0.07 | 100a | 0.117 ± 0.008 | 0.2 (0.1–0.2) | 0.4 (0.3–0.4) | 100.0 | 0.809 | ||
| 1% | - | - | 79.2 ± 9.5c | 0.008 ± 0.000 | 2.9 (2.1–4.3) | 5.6 (4.2–8.6) | 590.8 | 0.246 | ||
| 70% | - | - | 0h | ns | ns | ns | ns | ns | ||
| ANOVA D | 119; | |||||||||
| d-limonene | 0.5 | 4.83 | 0.8 ± 0.2f | 0.002 ± 0.001 | 20.1 (-) | 29.2 (-) | 69.3 | 0.322 | 3.1 (1.6–4.3) | |
| 1 | 6.70 | 0.8 ± 0.2f | 0.004 ± 0.001 | 14.5 (10.4–28.5) | 20.6 (14.4–42.4) | 47.7 | 0.996 | |||
| 2.5 | 0.19 | 51.4 ± 6.1d | 0.035 ± 0.000 | 0.6 (0.4–1.2) | 1.0 (0.8–1.5) | 79.3 | 0.510 | |||
| 5 | 0.10 | 100a | 0.124 ± 0.008 | 0.3 (0.2–0.3) | 0.4 (0.4–0.5) | 80.4 | 0.803 | |||
| trans-anethole | 0.5 | 4.40 | 1.6 ± 0.3e | 0.004 ± 0.002 | 13.4 (9.7–22.6) | 18.4 (13.8–35.6) | 30.8 | 1.000 | 2.4 (1.5–3.9) | |
| 1 | 4.43 | 1.6 ± 1.0e | 0.004 ± 0.001 | 13.3 (9.9–24.5) | 18.7 (13.5–36.3) | 30.4 | 0.055 | |||
| 2.5 | 0.16 | 86.4 ± 6.3c | 0.241 ± 0.005 | 0.5 (0.3–0.6) | 0.8 (0.4–1.0) | 88.2 | 0.752 | |||
| 5 | 0.10 | 100a | 0.079 ± 0.005 | 0.3 (-) | 0.6 (-) | 94.8 | 0.632 | |||
| 2.5% | - | 0.03 | 100a | 0.540 ± 0.040 | 0.1 (-) | 0.1 (-) | 2.4 | 0.825 | ||
| 2.5% | - | 0.10 | 100a | 0.106 ± 0.007 | 0.3 (0.2–0.3) | 0.5 (0.4–0.5) | 93.3 | 0.751 | ||
| 1% | - | - | 95.2 ± 8.7b | 0.011 ± 0.001 | 3.1 (2.5–3.6) | 4.8 (4.1–6.1) | 265.0 | 0.450 | ||
| 70% | - | - | 0g | ns | ns | ns | ns | ns | ||
| ANOVA D | 119; |
LAI = Larvicidal activity index; LAI <1.0 signifies that the treatment was more toxic than 1% w/w temephos; LAI >1.0 signifies that the treatment was less toxic than 1% w/w temephos.
LT50, LT90 = Lethal Time for 50% and 90% mortality with 95% confidence limit; LCL = lower confidence limit; UCL = upper confidence limit.
χ2 = Chi-square value with α = 0.05.
R = Regression coefficient.
LC50 = Lethal Concentration for 50% mortality with 95% confidence limit.
ns = not significant.
The means in each row against each mosquito species that are followed by different letters are significantly different (P < 0.05, by ANOVA and Duncan's Multiple Range Test).
Mortality rate at 72 h, lethal time for 50% and 90% mortality, and lethal concentration for 50% mortality of every treatment against the pupae of Ae. aegypti and Ae. albopictus.
| Mosquito Species | Treatment | Conc. (%) | Mortality (%) ± SD at 72 h | Slope ±SE | LT50 | LT90 | χ2 | LC50 | |
|---|---|---|---|---|---|---|---|---|---|
| d-limonene | 0.5 | 0f | - | - | - | - | - | 3.7 (2.8–4.7) | |
| 1 | 2.4 ± 1.4d | 0.000 ± 0.000 | 197.8 (131.2–465.0) | 197.8 (1297.8–465.0) | 106.4 | 0.074 | |||
| 2.5 | 53.1 ± 3.5c | 0.001 ± 0.000 | 45.3 (40.5–48.7) | 55.2 (48.5–58.6) | 134.2 | 0.085 | |||
| 5 | 94.4 ± 5.3b | 0.002 ± 0.000 | 23.8 (16.3–35.5) | 59.2 (44.6–90.4) | 872.1 | 0.023 | |||
| trans-anethole | 0.5 | 0.8 ± 0.2e | 0.001 ± 0.000 | 163.2 (119.9–277.2) | 247.8 (178.5–433.0) | 94.9 | 0.288 | 3.3 (2.5–3.9) | |
| 1 | 3.2 ± 1.1d | 0.000 ± 0.000 | 142.5 (103.0–260.2) | 218.1 (153.8–413.6) | 172.5 | 0.020 | |||
| 2.5 | 52.6 ± 4.3c | 0.002 ± 0.000 | 47.9 (45.5–52.5) | 58.1 (56.5–60.1) | 122.5 | 0.345 | |||
| 5 | 100a | 0.005 ± 0.000 | 6.9 (6.2–7.7) | 11.5 (10.4–12.9) | 126.6 | 0.824 | |||
| 2.5% | - | 100a | 0.031 ± 0.003 | 1.5 (1.4–1.8) | 2.2 (2.0–2.6) | 39.7 | 0.360 | ||
| 2.5% | - | 100a | 0.003 ± 0.003 | 15.3 (14.2–16.6) | 23.8 (21.9–26.0) | 94.0 | 0.823 | ||
| 1% | - | 0f | ns | ns | ns | ns | ns | ||
| 70% | - | 0f | ns | ns | ns | ns | ns | ||
| ANOVA D | 119; | ||||||||
| d-limonene | 0.5 | 1.6 ± 1.16e | 0.000 ± 0.000 | 161.0 (120.2–288.7) | 224.3 (162.3–422.0) | 22.4 | 1.000 | 3.7 (2.8–4.7) | |
| 1 | 2.4 ± 1.8d | 0.000 ± 0.000 | 179.8 (126.1–413.7) | 249.9 (169.6–604.7) | 27.6 | 0.283 | |||
| 2.5 | 43.2 ± 8.5c | 0.001 ± 0.000 | 53.2 (48.3–59.9) | 64.4 (58.1–70.2) | 153.5 | 0.170 | |||
| 5 | 89.6 ± 9.1b | 0.002 ± 0.000 | 28.5 (23.3–35.6) | 53.2 (44.3–67.3) | 486.0 | 0.620 | |||
| trans-anethole | 0.5 | 2.4 ± 1.8d | 0.000 ± 0.000 | 207.7 (139.4–508.8) | 2967.7 (194.4–752.9) | 40.1 | 0.178 | 3.4 (2.5–3.9) | |
| 1 | 2.6 ± 2.2d | 0.000 ± 0.000 | 174.5 (-) | 232.7 (-) | 16.3 | 0.333 | |||
| 2.5 | 41.7 ± 9.4c | 0.001 ± 0.000 | 57.6 (54.3–60.5) | 60.4 (58.2–65.5) | 785.1 | 0.781 | |||
| 5 | 86.4 ± 8.7b | 0.002 ± 0.000 | 28.8 (23.3–36.3) | 55.8 (46.2–71.2) | 516.1 | 0.528 | |||
| 2.5% | - | 100a | 0.009 ± 0.001 | 5.2 (4.8–5.7) | 7.6 (7.0–8.5) | 98.9 | 0.979 | ||
| 2.5% | - | 100a | 0.005 ± 0.000 | 7.9 (7.3–8.6) | 12.4 (11.5–13.6) | 86.2 | 0.903 | ||
| 1% | - | 0f | ns | ns | ns | ns | ns | ||
| 70% | - | 0f | ns | ns | ns | ns | ns | ||
| ANOVA D | 119; |
LT50, LT90 = Lethal Time for 50% and 90% mortality with 95% confidence limit; LCL = lower confidence limit; UCL = upper confidence limit.
χ2 = Chi-square value with α = 0.05.
R = Regression coefficient.
LC50 = Lethal Concentration for 50% mortality with 95% confidence limit.
ns = not significant.
The means in each row against each mosquito species followed by different letters are significantly different (P < 0.05, by ANOVA and Duncan's Multiple Range Test).
Figure 4Induced morphological aberrations at time of death of treated Ae. aegypti larvae and pupae: (a) normal larvae (NL); (b) deformed larva (DL); (c) larvae died before coming completely out of the larval exoskeleton (PP); (d) pupae came completely out of the larvae exoskeleton, but with a different color than the normal color (WP); (e) dead normal brown pupa (BP); (f) deformed pupa exhibited the appearance of an elephant head (DP); (g) adult mosquitoes died as they were emerging from their exoskeleton (PA); (h) survived adults with morphological defects (DA); and (i) normal adult (NA).
Figure 5Synergistic effects of combined EO and EO constituent, Z. limonella EO + d-limonene (a) and I. verum EO + trans-anethole (b) in terms of mortality rate against larvae and pupae of Ae. aegypti and Ae. albopictus. Note: Synergistic index (SI) = [LT50 of combined EO / LT50 of individual EO]: SI < 1 indicated a synergistic effect; SI >1 indicated an antagonistic effect; and SI = 1 indicated a no synergistic effect (Aungtikun et al., 2021).
Figure 6Morphological changes at the head (H), thorax (TH), abdomen (AB), anal papillae (AP), and respiratory siphon (RS) of treated Ae. aegypti larvae induced by control (a–c), d-limonene (d–f), trans-anethole (g–i), and a combined EO and EO constituent formulation (j–l).
Percentage of treated fourth-instar larvae of Ae. aegypti and Ae. albopictus that died with each type of morphological abnormality.
| Mosquito Species | Treatment | Conc. (%) | Stage at death (%) | Mortality (%) | Normally-developed adults (NA) (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NL | DL | PP | WP | DP | BP | PA | DA | |||||
| d-limonene | 0.5 | - | - | 4 | - | - | - | 0.8 | - | 4.8 | 95.2 | |
| 1 | 18.4 | - | 1.6 | - | - | 12 | 1.6 | 1.6 | 35.2 | 64.8 | ||
| 2.5 | 30.6 | - | 5 | - | - | 10 | 3 | 4 | 52.6 | 47.4 | ||
| 5 | 96.8 | - | - | - | - | 3.2 | - | - | 100 | - | ||
| trans-anethole | 0.5 | 3.2 | - | 2.4 | - | - | 2.4 | - | - | 8.0 | 92.0 | |
| 1 | 84 | - | - | - | - | 7.2 | 1.6 | - | 92.8 | 7.2 | ||
| 2.5 | 95 | - | - | - | - | 2.5 | - | - | 97.5 | 2.5 | ||
| 5 | 96 | - | - | - | - | 4 | - | - | 100 | - | ||
| 2.5% | - | 86 | 14 | - | - | - | - | - | - | 100 | - | |
| 2.5% | - | 44 | 46 | - | - | 10 | - | - | - | 100 | - | |
| 1% | - | 76 | - | 3.2 | - | - | - | - | - | 79.2 | 20.8 | |
| 70% | - | - | - | - | - | - | - | - | - | 0 | 100 | |
| d-limonene | 0.5 | - | - | - | - | - | 0.8 | - | - | 0.8 | 99.2 | |
| 1 | 0.8 | - | - | - | - | - | - | - | 0.8 | 99.2 | ||
| 2.5 | 50 | - | 1.4 | - | - | - | - | - | 51.4 | 48.6 | ||
| 5 | 99.2 | - | 0.8 | - | - | - | - | - | 100 | - | ||
| trans-anethole | 0.5 | 0.8 | - | 0.8 | - | - | - | - | - | 1.6 | 98.4 | |
| 1 | - | - | - | - | - | 1.6 | - | - | 1.6 | 98.4 | ||
| 2.5 | 85 | - | - | - | - | 1.4 | - | - | 86.4 | 13.6 | ||
| 5 | 100 | - | - | - | - | - | - | - | 100 | - | ||
| 2.5% | - | 60 | 38 | - | 2 | - | - | - | - | 100 | - | |
| 2.5% | - | 32 | 54 | 9 | 5 | - | - | - | - | 100 | - | |
| 1% | - | 84.8 | - | - | - | - | 4 | - | - | 88.8 | 11.2 | |
| 70% | - | - | - | - | - | - | - | - | - | 0 | 100 | |
Note: NL = normal larva, DL = deformed larva, PP = pre-pupa (pupa that has not emerged completely out of the larval exoskeleton), WP = white pupa, DP = deformed pupa, BP = dead normal brown pupa, PA = adult still attached to pupal case, DA = deformed Adult, and NA = normal adult.
Figure 7Morphological changes at the head (H), abdomen (AB), and respiratory trumpets (RT) of treated Ae. aegypti pupae induced by control group (a–b), d-limonene (c–d), trans-anethole (e–f), and a combined EO and EO constituent formulation (g–h).
Percentage of treated pupae of Ae. aegypti and Ae. albopictus that died with each type of morphological abnormality.
| Mosquito Species | Treatment | Conc. (%) | Stage at death (%) | Mortality (%) | Normally-developed adults (NA) (%) | |||
|---|---|---|---|---|---|---|---|---|
| BP | DP | PA | DA | |||||
| d-limonene | 0.5 | - | - | - | - | - | 100 | |
| 1 | 1.6 | - | 0.8 | - | 2.4 | 97.6 | ||
| 2.5 | 52 | - | 1.1 | - | 53.1 | 46.9 | ||
| 5 | 93.6 | - | 0.8 | - | 94.4 | 5.6 | ||
| trans-anethole | 0.5 | 0.8 | - | - | - | 0.8 | 99.2 | |
| 1 | 2.4 | - | 0.8 | - | 3.2 | 96.8 | ||
| 2.5 | 51 | - | 1.6 | - | 52.6 | 47.4 | ||
| 5 | 100 | - | - | - | 100 | - | ||
| 2.5% | - | 82 | 18 | - | - | 100 | - | |
| 2.5% | - | 60 | 36 | 4 | - | 100 | - | |
| 1% | - | - | - | - | - | - | 100 | |
| 70% | - | - | - | - | - | - | 100 | |
| d-limonene | 0.5 | - | - | 1.6 | - | 1.6 | 98.4 | |
| 1 | 2.4 | - | - | - | 2.4 | 97.6 | ||
| 2.5 | 40.2 | - | 2 | 1 | 43.2 | 56.8 | ||
| 5 | 77.6 | - | 8 | 4 | 89.6 | 14.4 | ||
| trans-anethole | 0.5 | - | - | 2.4 | - | 2.4 | 97.6 | |
| 1 | 2.6 | - | - | - | 2.6 | 97.4 | ||
| 2.5 | 39 | 1.2 | 1.5 | 41.7 | 58.3 | |||
| 5 | 72 | - | 5.6 | 8.8 | 86.4 | 13.6 | ||
| 2.5% | - | 86 | 14 | - | - | 100 | - | |
| 2.5% | - | 72 | 28 | - | - | 100 | - | |
| 1% | - | - | - | - | - | - | 100 | |
| 70% | - | - | - | - | - | - | 100 | |
Note: BP = dead normal brown pupa, DP = deformed pupa, PA = adult still attached to pupal case, DA = deformed Adult, NA = normal adult.